world
South China Morning Post World
China Becomes First to Approve Novel Narcolepsy Therapy Ahead of US, Japan, and Europe
The National Medical Products Administration (NMPA) in China has approved a new rare-disease treatment for narcolepsy type 1, marking a global first in drug approval and highlighting China's growing role in biopharmaceutical innovation.